Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up / Mukherjee, D; Topol, Ej; Bertrand, Me; Kristensen, Sd; Herrmann, Hc; Neumann, Fj; Yakubov, Sj; Bassand, Jp; Mcclure, Rr; Stone, Gw; Ardissino, D; Moliterno, Dj. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 26:23(2005), pp. 2524-2528. [10.1093/eurheartj/ehi459]

Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up

Ardissino D;
2005-01-01

2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up / Mukherjee, D; Topol, Ej; Bertrand, Me; Kristensen, Sd; Herrmann, Hc; Neumann, Fj; Yakubov, Sj; Bassand, Jp; Mcclure, Rr; Stone, Gw; Ardissino, D; Moliterno, Dj. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 26:23(2005), pp. 2524-2528. [10.1093/eurheartj/ehi459]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2883614
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 18
social impact